CICCHIELLO, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 523
EU - Europa 303
AS - Asia 145
OC - Oceania 1
SA - Sud America 1
Totale 973
Nazione #
US - Stati Uniti d'America 521
IT - Italia 129
DE - Germania 68
SG - Singapore 63
IE - Irlanda 34
CN - Cina 31
RU - Federazione Russa 24
SE - Svezia 23
HK - Hong Kong 18
ID - Indonesia 11
IN - India 11
FI - Finlandia 6
FR - Francia 5
VN - Vietnam 5
BE - Belgio 3
GB - Regno Unito 3
RO - Romania 3
TR - Turchia 3
CA - Canada 2
JP - Giappone 2
UA - Ucraina 2
AU - Australia 1
CL - Cile 1
LI - Liechtenstein 1
LT - Lituania 1
NL - Olanda 1
PK - Pakistan 1
Totale 973
Città #
Ann Arbor 270
Singapore 59
Frankfurt am Main 54
Milan 44
Dublin 34
Wilmington 26
Chandler 23
Ashburn 21
Fairfield 21
Hong Kong 18
New York 18
Santa Clara 15
Jakarta 11
Monza 10
Princeton 10
Shanghai 9
Seattle 7
Houston 6
Lecco 6
Cambridge 5
Dong Ket 5
Falls Church 4
Guangzhou 4
Helsinki 4
Lawrence 4
San Diego 4
Torino 4
Torre Del Greco 4
Beijing 3
Bergamo 3
Broni 3
Brussels 3
Hyderabad 3
Kocaeli 3
Lissone 3
Pune 3
Woodbridge 3
Altamura 2
Bad Kreuznach 2
Boardman 2
Fremont 2
Gerenzago 2
Inzago 2
Lambesc 2
Lappeenranta 2
London 2
Moscow 2
Munich 2
Portici 2
Sacramento 2
Andover 1
Annone Di Brianza 1
Bangalore 1
Bari 1
Bhubaneswar 1
Bioglio 1
Carate Brianza 1
Changsha 1
Dottingen 1
Duncan 1
Faisalabad 1
Genoa 1
Huzhou 1
Jacksonville 1
Jinan 1
Leawood 1
Lockeford 1
Mainz 1
Marseille 1
Melegnano 1
Mumbai 1
Nanjing 1
Norwalk 1
Oakland 1
Paris 1
Poggio Renatico 1
Rho 1
Santiago Metropolitan 1
Sesto San Giovanni 1
Shenzhen 1
Taiyuan 1
Tianjin 1
Tokyo 1
Toronto 1
Traralgon 1
Verona 1
Vilnius 1
Waltham 1
Zhengzhou 1
Totale 792
Nome #
Validation of the Italian version of the full and abbreviated Trust in Oncologist Scale 239
Comparison of tumor microenvironment in primary and paired metastatic ER+/HER2- breast cancers: results of a pilot study 222
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 129
Neurofilament light chain serum levels as a possible paclitaxel-induced peripheral neurotoxicity biomarker: pilot and feasibility study. 128
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study 116
A possible biomarker for paclitaxel-induced peripheral neurotoxicity: Neurofilament light chain serum levels monitoring 81
How to Treat HR+/HER2-Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story 50
Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study 42
Totale 1.007
Categoria #
all - tutte 3.932
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.932


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202021 0 0 0 0 0 0 7 8 4 0 2 0
2020/2021289 2 5 8 15 30 23 27 47 45 34 27 26
2021/2022171 28 20 18 26 12 18 3 4 7 7 6 22
2022/2023177 14 43 19 6 7 20 15 8 6 23 13 3
2023/2024179 10 17 4 14 14 37 26 10 13 1 12 21
2024/2025170 14 52 43 15 32 14 0 0 0 0 0 0
Totale 1.007